Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study

INTRODUCTION: Given the growing interest and use of interleukin-17 inhibitors (anti-IL17) for the treatment of psoriatic arthritis (PsA), an observational study has been conducted to characterize the patient profile, treatment patterns, and persistence of ixekizumab or secukinumab in patients with P...

Descripción completa

Detalles Bibliográficos
Autores principales: Joven, Beatriz, Manteca, Concepción Fito, Rubio, Esteban, Raya, Enrique, Pérez, Alba, Hernández, Raquel, Manrique, Sara, Núñez, Mercedes, Díaz-Cerezo, Silvia, Moyano, Sebastián, Lacetera, Alessandra, García-Vicuña, Rosario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611868/
https://www.ncbi.nlm.nih.gov/pubmed/37804475
http://dx.doi.org/10.1007/s12325-023-02693-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611868/
https://www.ncbi.nlm.nih.gov/pubmed/37804475
http://dx.doi.org/10.1007/s12325-023-02693-w

Ejemplares similares